Clinical trial
Open-Label Intravenous Subanesthetic Ketamine for Adolescents With Treatment-Resistant Depression
NCT02078817 is registered in ClinicalTrials.gov with University of Minnesota as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Open-Label Intravenous Subanesthetic Ketamine for Adolescents With Treatment-Resistant Depression
- Lead sponsor
- University of Minnesota
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- September 30, 2014
- Completion date
- March 31, 2018
- Enrollment
- 14 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.